Search hospitals > Connecticut > New Haven
Yale Cancer Center
Claim this profileNew Haven, Connecticut 06510
Global Leader in Solid Tumors
Global Leader in Tumors
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
408 reported clinical trials
39 medical researchers
Summary
Yale Cancer Center is a medical facility located in New Haven, Connecticut. This center is recognized for care of Solid Tumors, Tumors, Cancer, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Yale Cancer Center is involved with conducting 408 clinical trials across 273 conditions. There are 39 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Joseph W. Kim, MD.Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Tumors
Global LeaderStage IV
Stage III
MSI-H positive
Top PIs
Patricia M LorussoYale Cancer Center3 years of reported clinical research
Studies Tumors
Studies Solid Tumors
20 reported clinical trials
36 drugs studied
Alessandro SantinSmilow Cancer Hospital at Yale New Haven4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
15 reported clinical trials
24 drugs studied
Amer M. ZeidanYale Cancer Center3 years of reported clinical research
Studies Leukemia
Studies Myelodysplastic Syndrome
14 reported clinical trials
23 drugs studied
Joseph W. Kim, MDYale University7 years of reported clinical research
Studies Cancer
Studies Prostate Cancer
11 reported clinical trials
23 drugs studied
Clinical Trials running at Yale Cancer Center
Breast Cancer
Solid Tumors
Tumors
Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Colorectal Cancer
Pancreatic Cancer
Endometrial Cancer
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine therapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who have had previous treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) and endocrine therapy, either in the locally advanced/metastatic or the adjuvant setting.
Recruiting2 awards Phase 37 criteria
Sacituzumab Govitecan
for Breast Cancer
The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG) can improve life spans of people with HR+/HER2- metastatic breast cancer and their tumor does not grow or spread when compared to currently available standard treatments, such as paclitaxel, nab-paclitaxel or capecitabine. The primary objective is to compare the effect of SG relative to the treatment of physician's choice (TPC) on progression-free survival (PFS).
Recruiting2 awards Phase 3
VLS-1488
for Advanced Cancer
This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.
Recruiting1 award Phase 1 & 26 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Yale Cancer Center?
Yale Cancer Center is a medical facility located in New Haven, Connecticut. This center is recognized for care of Solid Tumors, Tumors, Cancer, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Yale Cancer Center is involved with conducting 408 clinical trials across 273 conditions. There are 39 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Joseph W. Kim, MD.
Where is Yale Cancer Center located?
The Yale Cancer Center is located at 35 Park St, New Haven, CT 06519. For access, from I-95 or I-91, take the Route 34 connector and follow signs to the Air Rights Garage. From Wilbur Cross Parkway or Merritt Parkway, follow the respective directions to Route 34 or Ella T. Grasso Blvd, then to South Frontage Road, and enter the Air Rights Garage. Enter the building from the 4th floor of the parking garage and walk through the bridge to Smilow Cancer Hospital.
Who should I call to ask about financial aid or insurance network?
**Yale Cancer Center Hospital Financial Assistance and Insurance Departments**
**Financial Assistance:**
- **Phone:** 855-547-4584
- **Website:** [Financial Assistance Guidelines](https://www.ynhhs.org/patients-visitors/billing-insurance/FAP-guidelines)
- **Programs:**
- **Free Care:** For individuals with family income less than 2.5 times the federal poverty level.
- **Discounted Care:** For uninsured patients with family income ≤ 5.5 times the Federal Poverty Level.
- **Sliding Scale:** For insured patients with family income ≤ 5.5 times the Federal Poverty Level.
**Insurance:**
- **Phone:** 855-547-4584
- **Website:** [Insurance and Billing](https://www.ynhhs.org/patients-visitors/billing-insurance/)
- **Services:**
- Customer Service Staff available for billing and insurance inquiries.
- Patient Registrar contacts patients before visits for insurance information.
- Medication Assistance Program (MAP) for patients with high medication costs.
What insurance does Yale Cancer Center accept?
The Yale Cancer Center accepts a wide range of insurance plans, including but not limited to Aetna, Anthem BC/BS, Cigna, ConnectiCare, Medicaid, Medicare, TRICARE, UnitedHealthcare, and WellCare of Connecticut Medicare Advantage. It's crucial to verify with your insurance carrier that your chosen healthcare provider is in-network before scheduling an appointment. Failure to do so may result in out-of-pocket expenses for services rendered.
What awards or recognition has Yale Cancer Center received?
Yale Cancer Center and Smilow Cancer Hospital at Yale New Haven are renowned for their pioneering contributions to cancer research, including the development of chemotherapy treatments and therapeutic agents. They boast the first university-based Medical Oncology section in the U.S. and lead in cancer biology research. With six research programs led by national experts, and as Connecticut's only National Cancer Institute-designated comprehensive cancer center, they offer advanced clinical trials and comprehensive care.